Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Chinese Patent Office
Covington
Daiichi Sankyo
Chubb
Mallinckrodt

Generated: June 26, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR EVZIO (AUTOINJECTOR)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Clinical Trials for Evzio (autoinjector)

Trial ID Title Status Sponsor Phase Summary
NCT00534378 Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector Completed U.S. Army Office of the Surgeon General Phase 1 Purpose of the study is to determine midazolam's safety and dose-linearity when delivered intramuscularly via an autoinjector. The proposed initial treatment dosage for seizures induced by exposure to nerve agents.
NCT00809146 Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed Medical University of South Carolina Phase 3 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed University of California, San Francisco Phase 3 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed Robert Silbergleit Phase 3 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00828204 Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects Completed Biogen Phase 3 The primary objective of the study was to evaluate the safe and effective use of the single-use autoinjector for the intramuscular (IM) delivery of liquid Avonex® (interferon beta-1a) in participants with multiple sclerosis (MS).
NCT00915577 Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe Completed Biogen Phase 3 Determine patient satisfaction with the single-use autoinjector for the delivery of pre-filled Avonex syringe.
Trial ID Title Status Sponsor Phase Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Evzio (autoinjector)

Condition Name

Condition Name for Evzio (autoinjector)
Intervention Trials
Healthy 6
Rheumatoid Arthritis 6
Multiple Sclerosis 4
Healthy Volunteers 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Evzio (autoinjector)
Intervention Trials
Arthritis, Rheumatoid 7
Arthritis 5
Multiple Sclerosis 4
Psoriasis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Evzio (autoinjector)

Trials by Country

Trials by Country for Evzio (autoinjector)
Location Trials
United States 133
Canada 7
Argentina 4
South Africa 3
Poland 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Evzio (autoinjector)
Location Trials
Arizona 11
Florida 10
Texas 9
California 9
Pennsylvania 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Evzio (autoinjector)

Clinical Trial Phase

Clinical Trial Phase for Evzio (autoinjector)
Clinical Trial Phase Trials
Phase 4 3
Phase 3 10
Phase 2 3
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Evzio (autoinjector)
Clinical Trial Phase Trials
Completed 21
Recruiting 6
Not yet recruiting 6
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Evzio (autoinjector)

Sponsor Name

Sponsor Name for Evzio (autoinjector)
Sponsor Trials
Boehringer Ingelheim 3
GlaxoSmithKline 3
Amgen 3
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Evzio (autoinjector)
Sponsor Trials
Industry 35
Other 8
U.S. Fed 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Citi
Baxter
Queensland Health
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.